Organigram Holdings Inc (NASDAQ: OGI) (TSX: OGI) has announced its rebranding to Organigram Global Inc, marking its evolution from a regional medical cannabis company to a global cannabis leader. The company, which has achieved the #1 market share position in Canada, unveiled a new visual identity including a new logo and website.
The expansion strategy includes a strategic investment in German cannabis leader Sanity Group, which holds 7% market share and distributes to over 2,000 pharmacies. The company is pursuing EU-GMP certification to scale exports and expects higher margins from international sales. Organigram currently exports to Australia, Germany, and the United Kingdom, with plans to increase shipments.
The company maintains two US investments: Open Book Extracts for hemp-derived products and Phylos Bioscience for cannabis genetics. Trading under the symbol ‘OGI’…
